Post-cancer fatigue is not associated with immune activation or altered cytokine production

Annals of Oncology

Volumn 23, Issue 11, 2012, Pages 2890-2895

  Cameron, B A ^a   Bennett, B ^a,b   Li, H ^a   Boyle, F ^c   Desouza, P ^d   Wilcken, N ^e   Friedlander, M ^b   Goldstein, D ^b   Lloyd, A R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MATER HOSPITAL   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e Westmead and Nepean Hospitals   (Australia)

Author keywords

Cytokines; Leukocyte; Post cancer fatigue; Symptom severity; Treatment related fatigue

Indexed keywords

EID: 84868155319     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds108     Document Type: Article

References (31)

1. Mock V, Atkinson A, Barsevick A et al. NCCN practice guidelines for cancerrelated fatigue. Oncology 2000; 14: 151-161.
2. Jager A. The pathogenesis of cancer related fatigue: could increased activity of proinflammatory cytokines be the common denominator? Eur J Cancer 2008; 44: 175-181.
3. Goldstein D, Bennett B, Friedlander M et al. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 2006; 6: 240.
4. Andrykowski MA, Schmidt JE, Salsman JM et al. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 2005; 23: 6613-6622.
5. Young. KE, White CAThe prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 2006; 60: 29-38.
6. Hartvig P, Aulin J, Hugerth M et al. Fatigue in cancer patients treated with cytotoxic drugs. J Oncol Pharm Pract 2006; 12: 155-164.
7. Nieboer P, Buijs C, Rodenhuis S et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol 2005; 23: 8296-8304.
8. Goldstein D, Bennet B, Webber K et al. Cancer-related fatigue in women with breast cancer: outcomes of a five year prospective cohort study. J Clin Oncol [2012;] April 16 [Epub ahead of print].
9. Vollmer-Conna U, Cameron B, Hadzi-Pavlovic D et al. Post-infective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis 2007; 45: 732-735.
10. Vollmer-Conna U, Fazou C, Cameron B et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289-1297.
11. Bennett B, Goldstein D, Friedlander M et al. The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study. J Pain Symptom Manage 2007; 34: 126-135.
12. Hickie I, Davenport T, Wakefield D et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 33: 7568-7575.
13. Herskind. C, Bamberg. M, Rodemann. HP The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol 1998; 174: 12-15.
14. Pusztai L, Mendoza TR, Reuben JM et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004; 25: 94-102.
15. Schubert C, Hong S, Natarajan L et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007; 21: 413-427.
16. Hickie I, Davenport T, Hadzi-Pavlovic D et al. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175: S10-S17.
17. Bennett B, Goldstein D, Lloyd A et al. Fatigue and psychological distress- exploring the relationship in women treated for breast cancer. Eur J Cancer [2004;] 40: 1689-1695.
18. Koschera A, Hickie I, Hadzi-Pavlovic D et al. Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Aust N Z J Psychiatry 1999; 33: 545-552.
19. Hadzi-Pavlovic D, Hickie I, Wilson A et al. Screening for prolonged fatigue syndromes: statistical and longitudinal validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 471-479.
20. Hickie I, Davenport T, Vernon SD et al. Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry 2009; 43: 25-35.
21. Anderson KO, Getto CJ, Mendoza TR et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 2003; 25: 307-318.
22. Unger ER, Nisenbaum R, Moldofsky H et al. Sleep assessment in a populationbased study of chronic fatigue syndrome. BMC Neurol 2004; 4: 6-8.
23. von Korff M, Ustun T, Ormel J et al. Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol 1996; 49: 297-303.
24. Cameron B, Bharadwaj M, Burrows J et al. Prolonged illness following EBV infection is associated with altered immunity but not elevated viral load. J Infect Dis 2006; 193: 664-671.
25. Ernster VNested case-control studies. Prev Med 1994; 23: 587-590.
26. Mills PJ, Parker B, Dimsdale JE et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 2005; 69: 85-96.
27. Bower JE, Ganz PA, Aziz N et al. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 2007; 21: 251-258.
28. Bower J, Ganz P, Aziz N, Fahey. J Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604-611.
29. Collado-Hidalgo A, Bower J, Ganz P et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12: 2759-2766.
30. Birgegard G, Aapro MS, Bokemeyer C et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 2005; [68:] 3-11.
31. Cameron B, Hirschberg D, Rosenberg-Hassan Y et al. Serum cytokine levels in post-infective fatigue syndrome. Clin Infect Dis 2010; 50: 278-280.